VEGFR2/CD309 anticorps (FITC)
Aperçu rapide pour VEGFR2/CD309 anticorps (FITC) (ABIN7648942)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- FITC-Linked Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Monoclonal Antibody
-
Purification
- Protein A + Protein G affinity chromatography
-
Isotype
- IgG2b kappa
-
-
-
-
Indications d'application
- For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 8.0, containing 0.05 % Proclin-300.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 4°C, protected from prolonged exposure to light.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- Vascular Endothelial Growth Factor Receptor 2
-
Sujet
- CD309, FLK1, VEGFR, KDR, A Type III Receptor Tyrosine Kinase, Kinase Insert Domain Receptor, Kinase Insert Domain Receptor, Fetal Liver Kinase-1
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-